PUBLISHER: Lucintel | PRODUCT CODE: 1386213
PUBLISHER: Lucintel | PRODUCT CODE: 1386213
The future of the global elastography imaging market looks promising with opportunities in the radiology/general imaging, cardiology, obstetrics/gynecology, urology, and vascular markets. The global elastography imaging market is expected to reach an estimated $5.32 billion by 2030 with a CAGR of 10.5% from 2024 to 2030. The major drivers for this market are growing cases of breast cancer and chronic liver diseases, increasing inclination towards minimally invasive surgery, and rising demand of advanced diagnostic techniques.
A more than 150-page report is developed to help in your business decisions.
The study includes a forecast for the global elastography imaging by modality, application, end use industry, and region.
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies elastography imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the elastography imaging companies profiled in this report include-
Lucintel forecasts that magnetic resonance elastography is expected to witness higher growth over the forecast period due to its increasing adoption in the diagnosis of advanced liver fibrosis.
Within this market, radiology/general imaging will remain the largest segment due to growing demand for high-quality diagnostic and therapeutic imaging capabilities as well as a rising awareness towards radiation dose concerns with other imaging modalities.
North America will remain the largest segment over the forecast period due to the increasing adoption of technologically advanced imaging systems, rising healthcare expenditure and the presence of major key players in the region.
Market Size Estimates: Elastography imaging market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Elastography imaging market size by modality, application, end use industry, and region in terms of value ($B).
Regional Analysis: Elastography imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different modalities, applications, end use industries, and regions for the elastography imaging market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the elastography imaging market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Answer: The global elastography imaging market is expected to reach an estimated $5.32 billion by 2030.
Answer: The global elastography imaging market is expected to grow with a CAGR of 10.5% from 2024 to 2030.
Answer: The major drivers for this market are growing cases of breast cancer and chronic liver diseases, increasing inclination towards minimally invasive surgery, and rising demand of advanced diagnostic techniques.
Answer: The future of the elastography imaging market looks promising with opportunities in the radiology/general imaging, cardiology, obstetrics/gynecology, urology, and vascular markets.
Answer: Some of the key elastography imaging companies are as follows:
Answer: Lucintel forecasts that magnetic resonance elastography is expected to witness higher growth over the forecast period due to its increasing adoption in the diagnosis of advanced liver fibrosis.
Answer: North America will remain the largest segment over the forecast period due to the increasing adoption of technologically advanced imaging systems, rising healthcare expenditure and the presence of major key players in the region.
Answer: Yes, Lucintel provides 10% customization without any additional cost.